“But Elsevier bought Mendeley and SSRN, and they’re OK, aren’t they?” | Sauropod Vertebra Picture of the Week

lterrat's bookmarks 2017-05-11


"Elsevier is a corporation that exists to enrich its shareholders. That’s not a controversial claim, it’s a simple statement of fact. And it’s not a criticism, it’s just recognising reality. We don’t even need to resent it: we just need to recognise it, and make our choices accordingly.

Now, from Elsevier’s perspective, Mendeley and SSRN, and indeed BioRN, are simply branches of Subway. They exist to make money for their shareholders. That’s their mission. Once more, not a criticism: just a fact.

But what this means is that the moment they are not making money, they will be shut down, just as the Cinderford branch of Subway would be. And, for that matter, just as BioMedNet, ChemWeb and ElsevierEngineering were shut down. Because Elsevier’s mission is not to further scholarship, it’s to make money. Again, not a criticism: just a fact."



From feeds:

Open Access Tracking Project (OATP) » lterrat's bookmarks


oa.new oa.comment oa.publishers oa.elsevier oa.mendeley oa.ssrn oa.monopoly oa.preprints oa.green oa.business_models oa.repositories oa.versions

Date tagged:

05/11/2017, 19:44

Date published:

05/11/2017, 15:44